Neuren Pharmaceuticals | NEU - Sales Revenues



Neuren Pharmaceuticals reported AUD194.1M in Sales Revenues for its fiscal semester ending in December of 2024.


Sales Change Date
Alaunos Therapeutics USD 0 4K Sep/2024
Avita Medical AUD 18.41M 7.89M Dec/2024
Clinuvel Pharmaceuticals AUD 55.92M 23.66M Jun/2024
Dianthus Therapeutics USD 193K 1.13M Jun/2025
Genetic Signatures AUD 4.37M 1.85M Jun/2024
Ionis Pharmaceuticals USD 452M 320M Jun/2025
Medical Developments International AUD 7.54M 0 Dec/2023
Neuren Pharmaceuticals AUD 194.1M 163.93M Dec/2024
Organon & Co 1.59B 80M Jun/2025
Paradigm Biopharmaceuticals AUD 433.66K 4.81M Dec/2024
PYC Therapeutics AUD 12.69M 6.11M Dec/2024
Starpharma Holdings AUD 2.43M 1.56M Dec/2024
Tectonic Therapeutic 0 0 Dec/2024
Telix Pharmaceuticals AUD 309.72M 109.32M Jun/2025
Viatris USD 3.57B 320M Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025